The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%.
(PRWEB) July 07, 2015
The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will hold the largest share of the aptamers market in 2015. The therapeutics development application is expected to be one of the fastest-growing applications between 2015 and 2020. Browse 74 data tables & 67 figures spread through 125 pages with in-depth TOC of "Aptamers Market" report @ http://www.rnrmarketresearch.com/aptamers-market-technology-trend-analysis-by-applications-therapeutics-diagnostics-biosensors-drug-discovery-biomarker-discovery-research-applications-with-market-landscape-analysis-global-market-report.html .
The geographic segments included in this report are the Americas, Europe, Asia, and Rest of the World (RoW). The geographic analysis reveals that the Americas are expected to account for the largest share in the global aptamers market in 2015. Europe is expected to register the fastest growth.
Key players in aptamers market include Aptagen LLC, Am Biotechnologies LLC, Aptamer Sciences Inc, Aptamer Solutions Ltd, Aptus Biotech S.L., Base Pair Biotechnologies Inc, Neoventures Biotechnology Inc, Somalogic Inc, Trilink Biotechnologies Inc and Vivonics Inc. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=104687 .
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global aptamers market and its sub segments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.The report provides qualitative insights about growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders. Inquire more here @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=104687 .
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:
- Product Development: Product portfolios of the top players in the aptamers market.
- Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the aptamers market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various aptamers products across geographies.
This is a premium research report priced at US$ 4650 for single user PDF license. Inquire for discount on this research @ http://www.rnrmarketresearch.com/contacts/discount?rname=104687 .
Related Market Reports:
"Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020” Companies profiled in this research report are Medtronic, Inc, Boston Scientific Corporation, ST. Jude Medical, Inc, Cyberonics, Inc, Nevro Corporation, Neurosigma, Inc, Neuropace, Inc, Biocontrol Medical, Synapse Biomedical, Inc and Neuronetics, Inc discussed in this research available at http://www.rnrmarketresearch.com/neuromodulation-market-spinal-cord-stimulation-scs-vagus-nerve-stimulation-vns-gastric-electrical-stimulation-ges-deep-brain-stimulation-dbs-sacral-nerve-stimulation-sns-tra-market-report.html .
"Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020” Companies profiled in this research report are Thermo Fisher Scientific, Inc, Promega Corporation, Qiagen N.V, Polyplus Transfection SA, Roche, Bio–Rad Laboratories Inc, Lonza Group, Sigma- Aldrich Corporation, Mirus Bio LLC and Maxcyte, Inc discussed in this research available at http://www.rnrmarketresearch.com/transfection-reagents-and-equipment-market-by-method-biochemical-calcium-phosphate-lipofection-dendrimers-physical-electroporation-nucleofection-viral-by-application-biomedical-protein-production-analysis-global-forecast-to-2-market-report.html .
Explore more In Biotechnology Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.